| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| snx-5422 | heat shock protein 90 alpha | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Carcinoma Neuroendocrine[MeSHID:D018278] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematologic Neoplasms[MeSHID:D019337] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
0.47 | phase 1/2 | unknown |
| snx-5422 | heat shock protein hsp 90-alpha | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Carcinoma Neuroendocrine[MeSHID:D018278] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematologic Neoplasms[MeSHID:D019337] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
0.47 | investigational | unknown |
| snx-5422 | heat shock protein 90 beta | NA | Clinical trial target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Carcinoma Neuroendocrine[MeSHID:D018278] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematologic Neoplasms[MeSHID:D019337] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
1.68 | phase 1/2 | unknown |
| snx-5422 | heat shock protein hsp 90-beta | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Carcinoma Neuroendocrine[MeSHID:D018278] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematologic Neoplasms[MeSHID:D019337] Non-Small Cell Lung Carcinoma[MeSHID:D002289] |
1.68 | investigational | unknown |
| click here to return to the previous page | ||||||||